Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.inVentiv Clinical, a division of inVentiv Health, has expanded Clinical Global Alliance with the additions of Protech Pharmaservices (PPC), Ecron Acunova and RDDA. The partners, along with ActivaCRO, are expected to broaden inVentiv Clinical Solutions' clinical research capabilities in Latin America, Asia, Europe and Africa and provide CRO service coverage in more than 50 countries.
Subscribe to our email newsletter
inVentiv Clinical said that PPC is the company’s Asia Pacific partner with its headquarters located in Taiwan. PPC is into serving the pharmaceutical, biotechnology, generic drug and medical device industries with a full spectrum of drug development solutions, including Phase I – IV clinical study management, bioavailability / bioequivalence studies, central laboratory, data management and statistical analysis.
Ecron Acunova, inVentiv Clinical’s partner for Europe, has its European headquarters in Frankfurt, Germany and operations across Europe, Asia and the America. Ecron Acunova is into providing services for Phase I – IV clinical research, including clinical trial management, clinical data management, PK/PD services and central lab for pharmaceutical, biotech, nutritional, medical diagnostic and device sponsors.
RDDA, inVentiv Clinical’s African partner, is a CRO based in Pretoria, South Africa and was founded by three partners. The company is into providing pharmaceutical industry with services in clinical trials in Africa. RDDA provides regulatory, project management and monitoring support across Africa including South Africa, Namibia, Botswana, Zambia, Kenya, Mozambique and Zimbabwe.
Michael Hlinak, president and CEO of inVentiv Clinical, said: “The expansion of our alliance is consistent with our mission to help clients accelerate quality clinical research in a cost-effective manner.
“By forging alliances with these partners, we are better positioned to provide our clients the flexible solutions and unmatched quality they have come to expect from inVentiv Clinical.”
Prasanna, founder and vice chairman of Ecron Acunova, said: “We are pleased to offer our delivery capabilities in Western and Eastern European countries, including Ukraine and Russia, and to the partners in the inVentiv Clinical network.”
Patrice Bassompierre, CEO of RDDA, said: “We at RDDA are indeed very proud to be part of this partnership. It is a great achievement for RDDA to be the partner in Southern Africa.”
Mario Boskis, president and chief operating officer of ActivaCRO, said: “With their incorporation, the inVentiv Clinical Global Alliance is presently in a position to cover many research locations.”